Your browser doesn't support javascript.
loading
Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients.
Caccamo, D; Gorgone, G; Currò, M; Parisi, G; Di Iorio, W; Menichetti, C; Belcastro, V; Parnetti, L; Rossi, A; Pisani, F; Ientile, R; Calabresi, P.
Affiliation
  • Caccamo D; Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, Via Consolare Valeria, Policlinico Universitario, Messina, 98125, Italy. dcaccamo@unime.it
Neuromolecular Med ; 9(3): 249-54, 2007.
Article in En | MEDLINE | ID: mdl-17914182
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Polymorphism, Genetic / Levodopa / Hyperhomocysteinemia / Methylenetetrahydrofolate Reductase (NADPH2) / Homocysteine / Antiparkinson Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Neuromolecular Med Journal subject: BIOLOGIA MOLECULAR / NEUROLOGIA Year: 2007 Type: Article Affiliation country: Italy
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Polymorphism, Genetic / Levodopa / Hyperhomocysteinemia / Methylenetetrahydrofolate Reductase (NADPH2) / Homocysteine / Antiparkinson Agents Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Neuromolecular Med Journal subject: BIOLOGIA MOLECULAR / NEUROLOGIA Year: 2007 Type: Article Affiliation country: Italy